dual sphingosine-1 phosphate receptor 1/sphingosine-1 phosphate receptor 5 agonists (LG Life Sciences)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namedual sphingosine-1 phosphate receptor 1/sphingosine-1 phosphate receptor 5 agonists (LG Life Sciences)
Drug Alias NameS1P1/S1P5 agonists (LG Life Sciences)multiple sclerosis therapy (LG Life Sciences)sphingosine-1 phosphate receptor 1/sphingosine-1 phosphate receptor 5 dual agonists (LG Life Sciences)dual S1P1/S1P5 agonists (LG Life Sciences)sphingosine-1 phosphate receptor 1/sphingosine-1 phosphate receptor 5 agonists (LG Life Sciences) +[7] 
ClassificationBiologics
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 agonistsImmunomodulatorsSphingosine 1-phosphate receptor 5 agonists +[4] 
TargetsSphingosine 1-Phosphate Receptor 1Sphingosine 1-phosphate receptor 5
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLg Chemical Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A